Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1975 2
1978 3
1979 3
1980 3
1981 3
1982 2
1983 8
1984 7
1985 4
1986 7
1987 6
1988 4
1989 11
1990 9
1991 11
1992 8
1993 13
1994 14
1995 15
1996 12
1997 13
1998 16
1999 24
2000 21
2001 15
2002 18
2003 32
2004 27
2005 37
2006 34
2007 48
2008 43
2009 50
2010 50
2011 48
2012 61
2013 70
2014 84
2015 101
2016 87
2017 91
2018 112
2019 98
2020 124
2021 104
2022 84
2023 71
2024 37

Text availability

Article attribute

Article type

Publication date

Search Results

1,501 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Hypertrophic cardiomyopathy 8"
Page 1
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).
Ho CY, Day SM, Ashley EA, Michels M, Pereira AC, Jacoby D, Cirino AL, Fox JC, Lakdawala NK, Ware JS, Caleshu CA, Helms AS, Colan SD, Girolami F, Cecchi F, Seidman CE, Sajeev G, Signorovitch J, Green EM, Olivotto I. Ho CY, et al. Circulation. 2018 Oct 2;138(14):1387-1398. doi: 10.1161/CIRCULATIONAHA.117.033200. Epub 2018 Aug 23. Circulation. 2018. PMID: 30297972 Free PMC article.
BACKGROUND: A better understanding of the factors that contribute to heterogeneous outcomes and lifetime disease burden in hypertrophic cardiomyopathy (HCM) is critically needed to improve patient management and outcomes. The Sarcomeric Human Cardiomyopathy R …
BACKGROUND: A better understanding of the factors that contribute to heterogeneous outcomes and lifetime disease burden in hypertrophic …
Exercise and hypertrophic cardiomyopathy: Two incompatible entities?
Basu J, Malhotra A, Papadakis M. Basu J, et al. Clin Cardiol. 2020 Aug;43(8):889-896. doi: 10.1002/clc.23343. Epub 2020 Feb 12. Clin Cardiol. 2020. PMID: 32048747 Free PMC article. Review.
A greater understanding of the pathogenic mechanisms underpinning hypertrophic cardiomyopathy (HCM) has translated to improved medical care and better survival of affected individuals. ...
A greater understanding of the pathogenic mechanisms underpinning hypertrophic cardiomyopathy (HCM) has translated to improved …
Hypokinetic hypertrophic cardiomyopathy: clinical phenotype, genetics, and prognosis.
Wasserstrum Y, Larrañaga-Moreira JM, Martinez-Veira C, Itelman E, Lotan D, Sabbag A, Kuperstein R, Peled Y, Freimark D, Barriales-Villa R, Arad M. Wasserstrum Y, et al. ESC Heart Fail. 2022 Aug;9(4):2301-2312. doi: 10.1002/ehf2.13914. Epub 2022 Apr 30. ESC Heart Fail. 2022. PMID: 35488723 Free PMC article.
AIMS: To describe the phenotype, genetics, and events associated with the development of hypertrophic cardiomyopathy (HCM) with reduced ventricular function (HCMr). ...CONCLUSIONS: Hypertrophic cardiomyopathy with reduced ejection fraction is associate …
AIMS: To describe the phenotype, genetics, and events associated with the development of hypertrophic cardiomyopathy (HCM) wit …
Hypertrophic cardiomyopathy centers.
Maron BJ. Maron BJ. Am J Cardiol. 2009 Oct 15;104(8):1158-9. doi: 10.1016/j.amjcard.2009.05.064. Epub 2009 Aug 28. Am J Cardiol. 2009. PMID: 19801041 No abstract available.
Characteristics and Outcomes of Elderly Patients With Hypertrophic Cardiomyopathy.
Alashi A, Smedira NG, Popovic ZB, Fava A, Thamilarasan M, Kapadia SR, Wierup P, Lever HM, Desai MY. Alashi A, et al. J Am Heart Assoc. 2021 Feb 2;10(3):e018527. doi: 10.1161/JAHA.120.018527. Epub 2021 Jan 28. J Am Heart Assoc. 2021. PMID: 33506683 Free PMC article.
Background We report characteristics and outcomes of elderly patients with hypertrophic cardiomyopathy (HCM) with basal septal hypertrophy and dynamic left ventricular outflow tract obstruction. ...
Background We report characteristics and outcomes of elderly patients with hypertrophic cardiomyopathy (HCM) with basal septal …
Utility of genetic testing in athletes.
Gray B, Semsarian C. Gray B, et al. Clin Cardiol. 2020 Aug;43(8):915-920. doi: 10.1002/clc.23289. Epub 2020 Jan 11. Clin Cardiol. 2020. PMID: 31925963 Free PMC article. Review.
Most inherited cardiac conditions have an underlying genetic basis to disease and genetic testing in an athlete can have diagnostic, prognostic and therapeutic implications, including guiding exercise recommendations. ...
Most inherited cardiac conditions have an underlying genetic basis to disease and genetic testing in an athlete can have diagnostic, prog …
Genetics of hypertrophic cardiomyopathy: A review of current state.
Sabater-Molina M, Pérez-Sánchez I, Hernández Del Rincón JP, Gimeno JR. Sabater-Molina M, et al. Clin Genet. 2018 Jan;93(1):3-14. doi: 10.1111/cge.13027. Epub 2017 Aug 17. Clin Genet. 2018. PMID: 28369730 Review.
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disease. ...There is an additional value of genetic testing in HCM for prognosis. Knowledge about genetics and functional studies are the basis of near future therapies....
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disease. ...There is an additional value of gene …
Childhood Hypertrophic Obstructive Cardiomyopathy and Its Relevant Surgical Outcome.
Zhu C, Wang S, Ma Y, Wang S, Zhou Z, Song Y, Yan J, Meng Y, Nie C. Zhu C, et al. Ann Thorac Surg. 2020 Jul;110(1):207-213. doi: 10.1016/j.athoracsur.2019.10.016. Epub 2019 Nov 28. Ann Thorac Surg. 2020. PMID: 31785290
BACKGROUND: Contemporary experiences regarding childhood hypertrophic obstructive cardiomyopathy are limited. This study aimed to describe the clinical presentation of childhood hypertrophic obstructive cardiomyopathy and its relevant surgical outcome. …
BACKGROUND: Contemporary experiences regarding childhood hypertrophic obstructive cardiomyopathy are limited. This study aimed …
Latent outflow tract obstruction in hypertrophic cardiomyopathy: Clinical characteristics and outcomes of septal myectomy.
Cui H, Schaff HV, Nishimura RA, Dearani JA, Geske JB, Ommen SR. Cui H, et al. J Thorac Cardiovasc Surg. 2022 Dec;164(6):1863-1869.e1. doi: 10.1016/j.jtcvs.2020.12.016. Epub 2020 Dec 10. J Thorac Cardiovasc Surg. 2022. PMID: 33468328 Review.
OBJECTIVE: This investigation analyzed clinical characteristics of patients with hypertrophic cardiomyopathy (HCM) and latent left ventricular outflow tract (LVOT) and outcomes following septal myectomy. ...The New York Heart Association functional classes and measu …
OBJECTIVE: This investigation analyzed clinical characteristics of patients with hypertrophic cardiomyopathy (HCM) and latent …
Cardiopulmonary Exercise Testing and Prognosis in Hypertrophic Cardiomyopathy.
Coats CJ, Rantell K, Bartnik A, Patel A, Mist B, McKenna WJ, Elliott PM. Coats CJ, et al. Circ Heart Fail. 2015 Nov;8(6):1022-31. doi: 10.1161/CIRCHEARTFAILURE.114.002248. Epub 2015 Sep 15. Circ Heart Fail. 2015. PMID: 26374874
The prognostic role of exercise gas exchange variables is unknown. METHODS AND RESULTS: Between 1998 and 2010, 1898 patients (age 4715 years, range 16-86 years; 67% male) with hypertrophic cardiomyopathy underwent cardiopulmonary exercise testing. ...CONCLUSI …
The prognostic role of exercise gas exchange variables is unknown. METHODS AND RESULTS: Between 1998 and 2010, 1898 patients (age 471 …
1,501 results